Otenzepad
Alternative Names: AFDX 116Latest Information Update: 16 Jul 2002
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Benzodiazepinones; Small molecules
- Mechanism of Action Muscarinic M2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias; Bradycardia